Allergy Therapeutics Free Cash Flow Generation Index
Allergy Therapeutics free cash flow generation index. Allergy Therapeutics (AGY) has a Free Cash Flow Generation Index of 0.69x as of December 2021. Free cash flow of GBX2.56 Million represents 1% of operating cash flow (GBX3.71 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Allergy Therapeutics (2003–2021)
Free cash flow generation index of Allergy Therapeutics from 2003 to 2021. Historical FCF Generation Index trend for Allergy Therapeutics across 11 annual periods. See financial flexibility index of Allergy Therapeutics to measure the company's free cash flow as a share of total liabilities.
Allergy Therapeutics Free Cash Flow Generation Index by Year (2003–2021)
Allergy Therapeutics free cash flow generation index by year from 2003 to 2021. Year-by-year Free Cash Flow Generation Index for Allergy Therapeutics. For the full cash flow conversion analysis, see Allergy Therapeutics cash flow conversion.
| Year | FCG Index | Free Cash Flow (GBX) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.70x | GBX5.95 Million | GBX8.52 Million | GBX2.56 Million | ▼ -11.8% |
| 2020 | 0.79x | GBX9.73 Million | GBX12.28 Million | GBX2.55 Million | ▲ +59.1% |
| 2019 | 0.50x | GBX2.79 Million | GBX5.60 Million | GBX2.81 Million | ▲ +106.7% |
| 2017 | -7.43x | GBX-1.32 Million | GBX178.00K | GBX1.50 Million | ▼ -1241.5% |
| 2015 | 0.65x | GBX2.03 Million | GBX3.12 Million | GBX1.09 Million | ▲ +10.9% |
| 2014 | 0.59x | GBX1.27 Million | GBX2.17 Million | GBX898.00K | ▼ -11.4% |
| 2013 | 0.66x | GBX1.61 Million | GBX2.43 Million | GBX821.00K | ▲ +17.8% |
| 2012 | 0.56x | GBX1.62 Million | GBX2.88 Million | GBX1.26 Million | ▲ +23819.6% |
| 2010 | 0.00x | GBX4.00K | GBX1.70 Million | GBX1.70 Million | ▼ -99.6% |
| 2004 | 0.60x | GBX1.15 Million | GBX1.91 Million | GBX760.00K | ▼ -25.4% |
| 2003 | 0.81x | GBX1.69 Million | GBX2.10 Million | GBX406.00K | — |